Back to Search
LYNN SPITLER, MD
MD
Allergy & Immunology (Internal Medicine) Physician
NPI: 1588867535Individual
Specialties, Licenses & Credentials
Allergy & Immunology (Internal Medicine) PhysicianPrimary
Internal Medicine — Allergy & Immunology
Code: 207RA0201X
C26446(CA)
Research & Publications (9)
Noninterferon-based adjuvant therapy for high-risk melanoma.
PMID 12382523·Expert Rev Anticancer Ther·2002
6-review
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.
PMID 10764421·J Clin Oncol·2000
3-trial
A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma.
PMID 19307996·J Immunother·2009
3-trial
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma.
PMID 16260693·J Clin Oncol·2005
3-trial
Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15-16 March 2002.
PMID 12140389·Melanoma Res·2002
8-other
Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer.
PMID 11870501·Br J Cancer·2002
3-trial
Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer.
PMID 10754524·Prostate·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 STANYAN ST, NORTHER CALIFORNIA MELANOMA CENTER ST. MARY'S MED CENTE
SAN FRANCISCO, CA 94117 - Phone
- (415) 750-5660
Quick Facts
- NPI
- 1588867535
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile